IRB Advisor – December 1, 2018
December 1, 2018
View Issues
-
Beware of Good and Bad News About the New Common Rule
The revised Common Rule changes will go into effect on Jan. 21, 2019, but it is quite likely IRBs will be adjusting their processes without all of the federal guidance they need.
-
Research Offers Clues on How to Improve Informed Consent
Deciding to make informed consent as comprehensible as possible is the easy part. What is not easy is determining how to accomplish this goal.
-
New Common Rule Suggests Changes for Informed Consent Documents
IRBs often spend too much time wordsmithing informed consent forms and not enough time on the big issue of comprehension, one IRB director says.
-
NIH Marshalling Data Defenses for All of Us Project
In a disarmingly frank lecture in an ethics training course at the National Institutes of Health, a leader of the landmark All of Us project shared some of the concerns that come with the immense responsibility of collecting data on 1 million people.
-
Researcher: Measure the Quality and Efficacy of IRBs
While it is intuitive that IRB oversight effectively protects human research subjects from ethical breaches and other risks, there is surprisingly little data on the quality and performance of review boards.
-
Small World, Big Data: International Research Collaborations
The National Institutes of Health has encouraged international collaboration in the Human Genome Project and other precision medicine research.
-
Ethical Challenges of Paying Addicted Participants
Financial compensation and HIV/HCV testing elicited trust and motivated an addicted population to participate in research, according to the authors of a recent report examining the ethical issues that can arise when intravenous drug addicts are paid for their research participation.